Viking Therapeutics (VKTX)
(Delayed Data from NSDQ)
$62.00 USD
-1.31 (-2.07%)
Updated Oct 1, 2024 03:59 PM ET
After-Market: $61.80 -0.20 (-0.32%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Earnings News For VKTX
-
Viking (VKTX) Q2 Earnings Beat, Stock Up on Pipeline Updates
-
Viking Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Viking (VKTX) to Report Q1 Earnings: What's in the Cards?
-
Viking Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
-
Viking Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
-
Viking Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
-
Viking Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
-
Viking Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update
-
Viking Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update